Transfemoral Transcatheter Aortic Valve Implantation (TF‐TAVI) for Patients With Left Ventricular Assist Device (LVAD) and Aortic Regurgitation
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70213 ↗Kurz gefasst
Fallbericht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Daniel Tai-Leung Chan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Queen Mary Hospital, Hong Kong, China. Hauptthemen laut MEDLINE: Heart-Assist Devices, Aortic Valve Insufficiency, Transcatheter Aortic Valve Replacement, Femoral Artery. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Aortic regurgitation (AR) develops in up to 25%−30% of patients with left ventricular assist device (LVAD). Treatment remains challenging since surgery confers significant peri‐operative risk and the lack of valvular calcification renders transfemoral transcatheter aortic valve implantation (TF‐TAVI) with non‐dedicated devices technically challenging. We present a case series wherein a TF J‐Valve system, a dedicated transcatheter heart valve for pure AR, emerges as an alternative treatment for AR in patients with an LVAD. We demonstrate successful deployment even in the presence of challenging anatomy including aortic root thrombus. Technical considerations when performing TF‐TAVI in LVAD patients are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Queen Mary Hospital, Hong Kong, China.
- Department of Medicine, Li Ka Shing Faculty of Medicine, Cardiology Division, The University of Hong Kong, Hong Kong, China.
- Cardiology Division, Department of Medicine, Queen Mary Hospital, Hong Kong, China.
- Cardiac Medical Unit, Grantham Hospital, Hong Kong, China.
- Department of Cardiothoracic Anaesthesia, Queen Mary Hospital, Hong Kong, China.
- Department of Cardiovascular Surgery, Mount Sinai Health System, New York, USA.
ORCID-Profile: Daniel Tai-Leung Chan, Ho-On Alston Conrad Chiu, Ka-Lam Wong
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Chan, D. T., Chiu, H. A. C., Wong, K. L., Un, K. C., Chan, K. E., Sze, S. Y., Tam, C. F., Wong, O. Y., Tang, G. H. L., & Lam, S. C. (2025). Transfemoral Transcatheter Aortic Valve Implantation (TF‐TAVI) for Patients With Left Ventricular Assist Device (LVAD) and Aortic Regurgitation. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70213
Vancouver
Chan DT, Chiu HAC, Wong KL, Un KC, Chan KE, Sze SY, et al. Transfemoral Transcatheter Aortic Valve Implantation (TF‐TAVI) for Patients With Left Ventricular Assist Device (LVAD) and Aortic Regurgitation. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70213
BibTeX
@article{Chan2025,
author = {Chan, Daniel Tai-Leung and Chiu, Ho-On Alston Conrad and Wong, Ka-Lam and Un, Ka-Chun and Chan, Kwong-Yue Eric and Sze, Shu-Yue and Tam, Chor-Cheung Frankie and Wong, On-Yat and Tang, Gilbert H L and Lam, Simon Cheung-Chi},
title = {Transfemoral Transcatheter Aortic Valve Implantation (TF‐TAVI) for Patients With Left Ventricular Assist Device (LVAD) and Aortic Regurgitation},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70213}
}
EUVIMED